Blue Note Therapeutics
Healthcare AI
Prescription digital therapeutics
Series A
Blue Note Therapeutics is a privately held prescription digital therapeutics company focused on evidence-based digital treatments for cancer-related psychological distress, anxiety, and depression. Its lead product, attune, is a prescription digital therapeutic for patients with cancer, and the company has pursued licensing and clinical collaborations with major cancer centers and oncology partners.
Company Details
- Website
- bluenotetherapeutics.com
- Headquarters
- San Francisco, California, United States
- Founded
- 2018
- Funding
- $31M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring